Get the Stockscreener App
76.70
1.46%
1.1205
Henry Schein Inc stock is traded at $76.70, with a volume of 356.59K.
It is up +1.46% in the last 24 hours and up +7.00% over the past month.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
See More
Previous Close:
$75.58
Open:
$75.65
24h Volume:
356.59K
Relative Volume:
0.26
Market Cap:
$9.03B
Revenue:
$12.50B
Net Income/Loss:
$314.00M
P/E Ratio:
31.43
EPS:
2.44
Net Cash Flow:
$421.00M
1W Performance:
+0.73%
1M Performance:
+7.00%
6M Performance:
+2.96%
1Y Performance:
+11.87%
1-Day Range:
$75.31
$76.80
1-Week Range:
$75.31
$76.95
52-Week Range:
$60.56
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Name
Henry Schein Inc
Sector
Industry
Phone
(631) 843-5500
Address
135 DURYEA RD, MELVILLE, NY
Compare HSIC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
76.70 | 8.90B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
824.12 | 101.25B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
338.90 | 65.52B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
CAH
Cardinal Health Inc
|
204.93 | 48.83B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
AHG
Akso Health Group Adr
|
1.59 | 900.69M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Aug-26-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-25-25 | Downgrade | Stifel | Buy → Hold |
| Jul-14-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-14-25 | Initiated | Wells Fargo | Equal Weight |
| Jan-06-25 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Jul-22-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-12-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-10-23 | Upgrade | Stifel | Hold → Buy |
| Aug-08-22 | Upgrade | UBS | Sell → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| Jan-31-22 | Initiated | Morgan Stanley | Underweight |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-01-21 | Resumed | Credit Suisse | Neutral |
| Feb-08-21 | Resumed | Piper Sandler | Overweight |
| Jan-04-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-03-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-07-20 | Upgrade | Goldman | Neutral → Buy |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-09-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-02-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| May-15-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Jan-17-19 | Initiated | UBS | Sell |
| Jan-03-19 | Downgrade | Evercore ISI | In-line → Underperform |
| Jan-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-08-18 | Reiterated | Barrington Research | Outperform |
| Oct-25-18 | Downgrade | Edward Jones | Hold → Sell |
| Oct-19-18 | Resumed | Goldman | Neutral |
| Oct-04-18 | Reiterated | Robert W. Baird | Outperform |
| Aug-07-18 | Reiterated | Stifel | Hold |
| Apr-24-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-04-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
View All
Henry Schein Inc Stock (HSIC) Latest News
Aug Technicals: Is Henry Schein Inc stock a bargain at current levels2025 Bull vs Bear & Verified Short-Term Trading Plans - moha.gov.vn
Can Henry Schein Inc stock surprise with earnings upsideInflation Watch & Verified Swing Trading Watchlists - moha.gov.vn
Dow Update: What technical signals suggest for Henry Schein Inc stockBear Alert & Daily Profit Maximizing Trade Tips - moha.gov.vn
Earnings Beat: Why Henry Schein Inc. stock remains undervalued2025 Pullback Review & Weekly High Potential Stock Alerts - moha.gov.vn
Why Henry Schein, Inc. (NASDAQ:HSIC) Could Be Worth Watching - 富途牛牛
Henry Schein (NASDAQ:HSIC) Has More To Do To Multiply In Value Going Forward - Yahoo Finance
One Fund Bought Up Henry Schein Stock Amid Record Quarterly Results and a New $200 Million Efficiency Plan - AOL.com
One Fund Bought Up Henry Schein Stock Amid Record Quarterly Results and a New $200 Million Efficiency Plan - The Motley Fool
Henry Schein to announce next CEO by mid-January - MassDevice
Henry Schein Joins J.P. Morgan Healthcare Event - Dentistry Today
Henry Schein to Participate in the J.P. Morgan Conference in January - The Joplin Globe
Marathon Asset Management Ltd Cuts Stock Position in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein Earnings Notes - Trefis
Henry Schein, Inc. (NASDAQ:HSIC) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Henry Schein expects to appoint next CEO by mid-January - MSN
Henry Schein, Inc. $HSIC Shares Purchased by Swedbank AB - MarketBeat
Assenagon Asset Management S.A. Decreases Stock Position in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein Board Advances CEO Succession and Transition - The Globe and Mail
Henry Schein extends private placement facilities to 2028 - MSN
How is Henry Schein's stock performance compared to other healthcare stocks? - MSN
Henry Schein Extends Private Placement Facilities to 2028 - The Globe and Mail
Henry Schein expects to name new CEO by mid-January 2026 - Investing.com Nigeria
Henry Schein Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Henry Schein (HSIC) to Appoint New CEO by January 2026 - GuruFocus
Henry Schein board advances CEO succession and transition - MSN
Henry Schein Says it Expects to Name Next CEO by Mid-January 2026 - marketscreener.com
Henry Schein expects to appoint next CEO by mid-January (HSIC:NASDAQ) - Seeking Alpha
Henry Schein Provides Update on CEO Search Process - The Joplin Globe
Henry Schein (HSIC) Extends Private Placement Shelf Facilities - GuruFocus
Henry Schein amends private shelf agreements to extend termination dates By Investing.com - Investing.com Nigeria
Henry Schein amends private shelf agreements to extend termination dates - Investing.com
Henry Schein amends private shelf agreement with PGIMSEC filing - marketscreener.com
Henry ScheinOn Dec 19, Amends Private Shelf Agreement With PGIMSEC Filing - TradingView — Track All Markets
Henry Schein Updates Multiple Financing Agreements With Major Lenders - TradingView — Track All Markets
Berger Financial Group Inc Invests $2.98 Million in Henry Schein, Inc. $HSIC - MarketBeat
Cash per share of Henry Schein, Inc. – BX:HS2 - TradingView — Track All Markets
Henry Schein (HSIC): Revisiting Valuation After Q3 2025 Earnings Beat and Upgraded Guidance - Sahm
Can Henry Schein Inc. stock maintain growth trajectoryWeekly Stock Recap & Smart Money Movement Tracker - Улправда
Thrivent Financial for Lutherans Has $4.97 Million Position in Henry Schein, Inc. $HSIC - MarketBeat
Why Henry Schein Inc. stock remains undervalued2025 Bull vs Bear & Safe Capital Growth Stock Tips - ulpravda.ru
Henry Schein One Drives Dentrix Ascend Growth - Dentistry Today
Can Henry Schein Inc. stock surprise with earnings upside2025 Fundamental Recap & Daily Chart Pattern Signals - DonanımHaber
Is Henry Schein Inc. stock recession proofWeekly Trade Recap & Free Risk Controlled Daily Trade Plans - DonanımHaber
Will Henry Schein Inc. stock attract ESG investors2025 Macro Impact & Weekly High Return Stock Forecasts - DonanımHaber
Is Henry Schein Inc. stock a safe haven assetWeekly Investment Summary & High Accuracy Investment Entry Signals - Улправда
Highlights and insights from Henry Schein’s new report predicting 2026 dental data - Dental Economics
DentScribe Joins Henry Schein One Exchange - Dentistry Today
Palmetto Grain Brokerage - Palmetto Grain Brokerage
How Is Henry Schein's Stock Performance Compared to Other Healthcare Stocks? - Barchart.com
DentScribe Joins Henry Schein One API Exchange as an Authorized Integration Vendor - StreetInsider
Traverse City Topic HENRY SCHEIN, INC. | News, Weather, Sports, Breaking News - WPBN
Henry Schein Inc Stock (HSIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Henry Schein Inc Stock (HSIC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DANIEL WILLIAM K | Director |
Aug 07 '25 |
Buy |
67.08 |
10,000 |
670,800 |
10,000 |
| LASKAWY PHILIP A | Director |
Mar 19 '25 |
Sale |
71.04 |
2,604 |
184,999 |
24,805 |
| Connett Bradford C | CEO, NA Distribution Group |
Mar 19 '25 |
Sale |
71.15 |
4,036 |
287,161 |
62,688 |
1.22%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):